124 related articles for article (PubMed ID: 2387538)
1. Stage III and stage IV endometrial carcinoma: a review of 41 cases.
Pliskow S; Penalver M; Averette HE
Gynecol Oncol; 1990 Aug; 38(2):210-5. PubMed ID: 2387538
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
[TBL] [Abstract][Full Text] [Related]
4. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma.
Connelly PJ; Alberhasky RC; Christopherson WM
Obstet Gynecol; 1982 May; 59(5):569-75. PubMed ID: 7070727
[TBL] [Abstract][Full Text] [Related]
7. Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965.
Homesley HD; Boronow RC; Lewis JL
Obstet Gynecol; 1976 Jan; 47(1):100-5. PubMed ID: 1246374
[TBL] [Abstract][Full Text] [Related]
8. Stage III carcinoma of the endometrium: a review of 41 cases.
Genest P; Drouin P; Girard A; Gerig L
Gynecol Oncol; 1987 Jan; 26(1):77-86. PubMed ID: 3792938
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of surgical staging for carcinoma of the endometrium.
Wolfson AH; Sightler SE; Markoe AM; Schwade JG; Averette HE; Ganjei P; Hilsenbeck SG
Gynecol Oncol; 1992 May; 45(2):142-6. PubMed ID: 1592280
[TBL] [Abstract][Full Text] [Related]
10. Stage I endometrial adenocarcinoma: treatment results in 835 patients.
Lotocki RJ; Copeland LJ; DePetrillo AD; Muirhead W
Am J Obstet Gynecol; 1983 May; 146(2):141-5. PubMed ID: 6846429
[TBL] [Abstract][Full Text] [Related]
11. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
12. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
13. Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors.
Bucy GS; Mendenhall WM; Morgan LS; Chafe WE; Wilkinson EJ; Marcus RB; Million RR
Gynecol Oncol; 1989 Jun; 33(3):290-5. PubMed ID: 2722051
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma.
Smith MR; Peters WA; Drescher CW
Am J Obstet Gynecol; 1994 Jun; 170(6):1677-81; discussion 1681-2. PubMed ID: 8203425
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in early carcinoma of the endometrium.
Genest P; Drouin P; Gerig L; Girard A; Stewart D; Prefontaine M
Am J Clin Oncol; 1987 Feb; 10(1):71-7. PubMed ID: 3825996
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma in the south of Israel: study of 231 cases.
Piura B; Bar-Dayan A; Cohen Y; Yanai-Inbar I; Glezerman M
J Surg Oncol; 1997 Nov; 66(3):189-95. PubMed ID: 9369965
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
19. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors.
Nori D; Hilaris BS; Tome M; Lewis JL; Birnbaum S; Fuks Z
Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):489-97. PubMed ID: 3104248
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; DiSaia PJ; Yordan E; Carson LF; Evers C
J Clin Oncol; 1994 Jul; 12(7):1408-14. PubMed ID: 8021731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
